HTRF - Her2 phospho-y1221/1222 kit - 500 tests 1 Kit
Produit ni repris ni échangé excepté en cas d’erreur du prestataire.
Points clés
The phospho-HER2 (Tyr1221/1222) assay is designed for the robust quantification of HER2-Erbb2 modulation when phosphorylated on Tyr1221/1222, an indicator of many types of cancer pathologies. Upregulation of HER2, or human epidermoid receptor 2, also known as ErbB2 receptor, is associated with human breast cancer and several others, such as ovarian, stomach, bladder, salivary, or lung carcinomas, making HER2 a key target for anti-cancer therapies.
Garantie
Garantie 0 Mois
Description
The phospho-HER2 (Tyr1221/1222) assay is designed for the robust quantification of HER2-Erbb2 modulation when phosphorylated on Tyr1221/1222, an indicator of many types of cancer pathologies. Upregulation of HER2, or human epidermoid receptor 2, also known as ErbB2 receptor, is associated with human breast cancer and several others, such as ovarian, stomach, bladder, salivary, or lung carcinomas, making HER2 a key target for anti-cancer therapies.
Caractéristiques
- Marque
- REVVITY
- Libellé produit fabricant
- Phospho-HER2 (Tyr1221/1222) cellular kit, 500 Tests
- Référence distributeur
- 64HR2PEG
- Référence fabricant
- 64HR2PEG
- Fournisseur
- REVVITY
- Reprise en cas d’erreur client
- non
- Lieu de fabrication
- France
- Lieu de stockage
- France
- Domaine de recherche
- biologie cellulaire
- Délai de péremption à la date de livraison
- 6 mois
- Soumis à carboglace
- oui
- Soumis à réglementation
- non
- Température de conservation (°C)
- -80 à -60 °C
- Type d’application
- PhosphoELISA
- Vendu par
- 1 kit
- Quantité
- N/A
- Nomenclature Nacres
- NA.84
- Nomenclature CEA
- SGP01
- Nomenclature IRSN
- 273
- Nomenclature INSERM
- NA.NA84
- Nomenclature CNRS
- NA84
- Nomenclature CHU
- 18.551
- Nomenclature DGOS
- LD11AOOO
- Type d'échantillon
- sérum, plasma, surnageant de culture cellulaire, tissu
- Certification
- RUO
